HAVCR2 and neoplasm: HMGB1 is reported to interact with TIM-3 on dendritic cells associated with tumor microenvironments and it is presumed that TIM-3 could negatively regulate innate immune responses promoted by HMGB1 and triggered by nucleic acids.